"German CDMO Rentschler Biopharma is expanding cCMP production of CureVac NV’s RNA-based COVID-19 vaccine candidate CVnCoV...."
Rentschler Biopharma to produce 100m doses of CureVac vaccine
020321 Rentschler Biopharma to produce 1
Download • 503KB
Medical - Pharma - Biotech - Medical Devices - Healthcare - Telemedicine - Healthcare Technology - Healthcare IT
Your Source For Worldwide Business and Financial Opportunities
MedNews on financings, strategic relationships, products, services and technology, including launches
MedTalks videos featuring conversations with management of companies with business or financial objectives